Interpretation of human epidermal growth factor receptor 2 (HER2) in situ hybridization assays using 2013 update of American Society of Clinical Oncology/College of American Pathologists HER2 Guidelines
- PMID: 24778404
- DOI: 10.1200/JCO.2013.53.9213
Interpretation of human epidermal growth factor receptor 2 (HER2) in situ hybridization assays using 2013 update of American Society of Clinical Oncology/College of American Pathologists HER2 Guidelines
Comment in
-
Reply to R. Bhargava et al and K. Lambein et al.J Clin Oncol. 2014 Jun 10;32(17):1857-9. doi: 10.1200/JCO.2014.55.0673. Epub 2014 Apr 28. J Clin Oncol. 2014. PMID: 24778389 No abstract available.
Comment on
-
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.J Clin Oncol. 2007 Jan 1;25(1):118-45. doi: 10.1200/JCO.2006.09.2775. Epub 2006 Dec 11. J Clin Oncol. 2007. PMID: 17159189
Similar articles
-
2013 update of the American Society of Clinical Oncology/College of American Pathologists guideline for human epidermal growth factor receptor 2 testing: impact on immunohistochemistry-negative breast cancers.J Clin Oncol. 2014 Jun 10;32(17):1856-7. doi: 10.1200/JCO.2013.54.2530. Epub 2014 Apr 28. J Clin Oncol. 2014. PMID: 24778399 No abstract available.
-
Impact of American Society of Clinical Oncology/College of American Pathologists guideline recommendations on HER2 interpretation in breast cancer.Hum Pathol. 2010 Jan;41(1):103-6. doi: 10.1016/j.humpath.2009.07.001. Epub 2009 Sep 16. Hum Pathol. 2010. PMID: 19762065
-
Gene protein detection platform--a comparison of a new human epidermal growth factor receptor 2 assay with conventional immunohistochemistry and fluorescence in situ hybridization platforms.Ann Diagn Pathol. 2015 Aug;19(4):203-10. doi: 10.1016/j.anndiagpath.2015.04.002. Epub 2015 Apr 7. Ann Diagn Pathol. 2015. PMID: 25921313
-
Predictive markers in breast cancer: An update on ER and HER2 testing and reporting.Semin Diagn Pathol. 2015 Sep;32(5):362-9. doi: 10.1053/j.semdp.2015.02.011. Epub 2015 Feb 7. Semin Diagn Pathol. 2015. PMID: 25770732 Review.
-
Current HER2 Testing Recommendations and Clinical Relevance as a Predictor of Response to Targeted Therapy.Clin Breast Cancer. 2015 Jun;15(3):171-80. doi: 10.1016/j.clbc.2014.11.009. Epub 2014 Dec 2. Clin Breast Cancer. 2015. PMID: 25516402 Review.
Cited by
-
Unraveling the chromosome 17 patterns of FISH in interphase nuclei: an in-depth analysis of the HER2 amplicon and chromosome 17 centromere by karyotyping, FISH and M-FISH in breast cancer cells.BMC Cancer. 2014 Dec 7;14:922. doi: 10.1186/1471-2407-14-922. BMC Cancer. 2014. PMID: 25481507 Free PMC article.
-
New ASCO/CAP guideline recommendations for HER2 testing increase the proportion of reflex in situ hybridization tests and of HER2 positive breast cancers.Virchows Arch. 2016 Feb;468(2):207-11. doi: 10.1007/s00428-015-1871-z. Epub 2015 Oct 31. Virchows Arch. 2016. PMID: 26521061
-
The ratio of CD8 + lymphocytes to tumor-infiltrating suppressive FOXP3 + effector regulatory T cells is associated with treatment response in invasive breast cancer.Discov Oncol. 2022 Apr 19;13(1):27. doi: 10.1007/s12672-022-00482-5. Discov Oncol. 2022. PMID: 35438346 Free PMC article.
-
A Validation Study of Human Epidermal Growth Factor Receptor 2 Immunohistochemistry Digital Imaging Analysis and its Correlation with Human Epidermal Growth Factor Receptor 2 Fluorescence In situ Hybridization Results in Breast Carcinoma.J Pathol Inform. 2020 Feb 4;11:2. doi: 10.4103/jpi.jpi_52_19. eCollection 2020. J Pathol Inform. 2020. PMID: 32154039 Free PMC article.
-
Invasive Micropapillary Carcinoma with CEP17 Monosomy of the Bilateral Breast: A Rare Case Report and Review of the Literature.Onco Targets Ther. 2020 Jul 2;13:6425-6432. doi: 10.2147/OTT.S251934. eCollection 2020. Onco Targets Ther. 2020. PMID: 32753884 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous